NANOG and cancer: Interestingly, FOXM1 depletion in human embryonic stem cells led to a disruption in proliferation but did not impact OCT4 and NANOG expression during in vitro differentiation [235], suggesting that the ability of FOXM1 to modulate pluripotency may be restricted to specific settings which cancer cells are able to exploit.